Global Computational Biology Market : Industry Analysis and Forecast (2019-2027)

Global Computational Biology Market was valued at US$ 2.5 Bn in 2019 and is expected to reach US$10.7Bn by 2027, at a CAGR of 19.93% during a forecast period.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

To know about the Research Methodology:-Request Free Sample Report

Global Computational Biology Market Dynamics:

The global computational biology market has witnessed significant growth in recent years because of its assistance in the field of biotechnology and medicine. Combing biology and computers, computational biology helps in drug breakthroughs and consequent development during the several stages of clinical trials. The wide use of computational biology in biotechnology and pharmaceuticals driving the market.

Lack of innovative drugs and increasing drug failures in later stages of development had taken its toll on the pharmaceutical industry, amounting to huge financial losses. However, adopting computational biology above a period of time has led to not just minimized clinical stage expenditure but also decreased the frequency of drug failures. This has mainly driven the computational biology market. Additionally, enhanced government funding and industrial support, as well as improved computational tools have driven the growth of the industry. The use of computational biology in modelling and simulation of pediatrics drug development is expected to open various doors for future expansion.

Cellular and biological simulation segment is expected to continue leading with over 34.0% market share by 2027. Computational cell modelling and biological simulation aid decipher the biological and physiological functions of cells. Increased unmet medical desires and burgeoning demand for personalized medicine are expected to shape the future growth of the application segment.

Commercial led the end use segment in 2019, attributed to the rise in the bioinformatics research, drug designing, and usage in personalized medicine. Such as, in August 2018, the European Union and India’s Department of Biotechnology (DBT) announced the fund of US$ 17.2 Mn towards research and innovation for the development of next-generation influenza virus to protect individuals worldwide.

Global Computational Biology Market Regional Insights:

North America is expected to contribute to the largest market share in the computational biology market in the coming years, because of increasing investments made in R&D activities for the discovery as well as the development of novel drugs. Also, the Asia Pacific is anticipated to witness steady growth during the forecast period, owing to increasing clinical trials in the region.

In Feb 2019, StemoniX Inc., the USA based provider of product and services for drug discovery and development, received funding of US$ 14.40 Mn from a group of investors. Brightstone Venture Capital was the major financer and was later combined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Computational Biology Market dynamics, structure by identifying and analyzing the market segments and project the global market size.

Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Computational Biology Market.

Global Computational Biology Market, Key Highlights:

• Global Computational Biology Market analysis and forecast, in terms of value.

• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Computational Biology Market

• Global Computational Biology Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

• Global Computational Biology Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

• Global Computational Biology Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Computational Biology Market are also profiled.

The report has considered the base year of 2019 and past four years trend. 2020 figures are at actuals, however due to different dynamics of year 2020, market forecast is not only dependent upon 2020, but on the basis of 2016-2020.

Scope of the Global Computational Biology Market: Inquire before buying

Global Computational Biology Market, by Application

• Cellular & Biological Simulation

o Computational Genomics

 Databases

 Infrastructure/Hardware

 Software & Services

o Computational Proteomics

o Pharmacogenomics

o Others (Transcriptomics/ Metabolomics)

• Drug Discovery & Disease Modelling

o Target Identification

o Target Validation

o Lead Discovery

o Lead Optimization

• Preclinical Drug Development

o Pharmacokinetic

o Pharmacodynamics

• Clinical Trials

o Phase I

o Phase II

o Phase III

• Human Body Simulation Software

Global Computational Biology Market, by Services

• In-house

• Contract

Global Computational Biology Market, by End Use

• Academics

• Industry

• Commercial

Global Computational Biology Market, by Region

• North America

• Europe

• Asia Pacific

• Middle East and Africa

• Latin America

Global Computational Biology Market Key Player

• DassaultSystèmes SE

• Certara

• Chemical Computing Group ULC

• Compugen Ltd

• Rosa & Co. LLC

• Genedata AG

• Insilico Biotechnology AG

• Leadscope Inc.

• Nimbus Discovery LLC

• Strand Life Sciences

• Schrodinger

• Simulation Plus Inc.

• Accelrys

• Entelos

• RhenoviaPharma Sa

• StemoniXInc

• Computational Genomics Laboratory

• Elucidata

• DNAnexus

• Simons Foundation

Comments are closed